1 Study Coverage
1.1 Aflibercept Biosimilars Product Introduction
1.2 Market by Type
1.2.1 Global Aflibercept Biosimilars Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Intravitreal Injection
1.2.3 Intravenous Injection
1.3 Market by Application
1.3.1 Global Aflibercept Biosimilars Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Wet Macular Degeneration
1.3.3 Metastatic Colorectal Cancer
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Aflibercept Biosimilars Sales Estimates and Forecasts 2017-2028
2.2 Global Aflibercept Biosimilars Revenue Estimates and Forecasts 2017-2028
2.3 Global Aflibercept Biosimilars Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Aflibercept Biosimilars Sales by Region
2.4.1 Global Aflibercept Biosimilars Sales by Region (2017-2022)
2.4.2 Global Sales Aflibercept Biosimilars by Region (2023-2028)
2.5 Global Aflibercept Biosimilars Revenue by Region
2.5.1 Global Aflibercept Biosimilars Revenue by Region (2017-2022)
2.5.2 Global Aflibercept Biosimilars Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Aflibercept Biosimilars Sales by Manufacturers
3.1.1 Global Top Aflibercept Biosimilars Manufacturers by Sales (2017-2022)
3.1.2 Global Aflibercept Biosimilars Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Aflibercept Biosimilars in 2021
3.2 Global Aflibercept Biosimilars Revenue by Manufacturers
3.2.1 Global Aflibercept Biosimilars Revenue by Manufacturers (2017-2022)
3.2.2 Global Aflibercept Biosimilars Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Aflibercept Biosimilars Revenue in 2021
3.3 Global Aflibercept Biosimilars Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Aflibercept Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Aflibercept Biosimilars Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Aflibercept Biosimilars Sales by Type
4.1.1 Global Aflibercept Biosimilars Historical Sales by Type (2017-2022)
4.1.2 Global Aflibercept Biosimilars Forecasted Sales by Type (2023-2028)
4.1.3 Global Aflibercept Biosimilars Sales Market Share by Type (2017-2028)
4.2 Global Aflibercept Biosimilars Revenue by Type
4.2.1 Global Aflibercept Biosimilars Historical Revenue by Type (2017-2022)
4.2.2 Global Aflibercept Biosimilars Forecasted Revenue by Type (2023-2028)
4.2.3 Global Aflibercept Biosimilars Revenue Market Share by Type (2017-2028)
4.3 Global Aflibercept Biosimilars Price by Type
4.3.1 Global Aflibercept Biosimilars Price by Type (2017-2022)
4.3.2 Global Aflibercept Biosimilars Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Aflibercept Biosimilars Sales by Application
5.1.1 Global Aflibercept Biosimilars Historical Sales by Application (2017-2022)
5.1.2 Global Aflibercept Biosimilars Forecasted Sales by Application (2023-2028)
5.1.3 Global Aflibercept Biosimilars Sales Market Share by Application (2017-2028)
5.2 Global Aflibercept Biosimilars Revenue by Application
5.2.1 Global Aflibercept Biosimilars Historical Revenue by Application (2017-2022)
5.2.2 Global Aflibercept Biosimilars Forecasted Revenue by Application (2023-2028)
5.2.3 Global Aflibercept Biosimilars Revenue Market Share by Application (2017-2028)
5.3 Global Aflibercept Biosimilars Price by Application
5.3.1 Global Aflibercept Biosimilars Price by Application (2017-2022)
5.3.2 Global Aflibercept Biosimilars Price Forecast by Application (2023-2028)
6 North America
6.1 North America Aflibercept Biosimilars Market Size by Type
6.1.1 North America Aflibercept Biosimilars Sales by Type (2017-2028)
6.1.2 North America Aflibercept Biosimilars Revenue by Type (2017-2028)
6.2 North America Aflibercept Biosimilars Market Size by Application
6.2.1 North America Aflibercept Biosimilars Sales by Application (2017-2028)
6.2.2 North America Aflibercept Biosimilars Revenue by Application (2017-2028)
6.3 North America Aflibercept Biosimilars Market Size by Country
6.3.1 North America Aflibercept Biosimilars Sales by Country (2017-2028)
6.3.2 North America Aflibercept Biosimilars Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Aflibercept Biosimilars Market Size by Type
7.1.1 Europe Aflibercept Biosimilars Sales by Type (2017-2028)
7.1.2 Europe Aflibercept Biosimilars Revenue by Type (2017-2028)
7.2 Europe Aflibercept Biosimilars Market Size by Application
7.2.1 Europe Aflibercept Biosimilars Sales by Application (2017-2028)
7.2.2 Europe Aflibercept Biosimilars Revenue by Application (2017-2028)
7.3 Europe Aflibercept Biosimilars Market Size by Country
7.3.1 Europe Aflibercept Biosimilars Sales by Country (2017-2028)
7.3.2 Europe Aflibercept Biosimilars Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Aflibercept Biosimilars Market Size by Type
8.1.1 Asia Pacific Aflibercept Biosimilars Sales by Type (2017-2028)
8.1.2 Asia Pacific Aflibercept Biosimilars Revenue by Type (2017-2028)
8.2 Asia Pacific Aflibercept Biosimilars Market Size by Application
8.2.1 Asia Pacific Aflibercept Biosimilars Sales by Application (2017-2028)
8.2.2 Asia Pacific Aflibercept Biosimilars Revenue by Application (2017-2028)
8.3 Asia Pacific Aflibercept Biosimilars Market Size by Region
8.3.1 Asia Pacific Aflibercept Biosimilars Sales by Region (2017-2028)
8.3.2 Asia Pacific Aflibercept Biosimilars Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Aflibercept Biosimilars Market Size by Type
9.1.1 Latin America Aflibercept Biosimilars Sales by Type (2017-2028)
9.1.2 Latin America Aflibercept Biosimilars Revenue by Type (2017-2028)
9.2 Latin America Aflibercept Biosimilars Market Size by Application
9.2.1 Latin America Aflibercept Biosimilars Sales by Application (2017-2028)
9.2.2 Latin America Aflibercept Biosimilars Revenue by Application (2017-2028)
9.3 Latin America Aflibercept Biosimilars Market Size by Country
9.3.1 Latin America Aflibercept Biosimilars Sales by Country (2017-2028)
9.3.2 Latin America Aflibercept Biosimilars Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Aflibercept Biosimilars Market Size by Type
10.1.1 Middle East and Africa Aflibercept Biosimilars Sales by Type (2017-2028)
10.1.2 Middle East and Africa Aflibercept Biosimilars Revenue by Type (2017-2028)
10.2 Middle East and Africa Aflibercept Biosimilars Market Size by Application
10.2.1 Middle East and Africa Aflibercept Biosimilars Sales by Application (2017-2028)
10.2.2 Middle East and Africa Aflibercept Biosimilars Revenue by Application (2017-2028)
10.3 Middle East and Africa Aflibercept Biosimilars Market Size by Country
10.3.1 Middle East and Africa Aflibercept Biosimilars Sales by Country (2017-2028)
10.3.2 Middle East and Africa Aflibercept Biosimilars Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Regeneron
11.1.1 Regeneron Corporation Information
11.1.2 Regeneron Overview
11.1.3 Regeneron Aflibercept Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Regeneron Aflibercept Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Regeneron Recent Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Overview
11.2.3 Sanofi Aflibercept Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sanofi Aflibercept Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi Recent Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Overview
11.3.3 Novartis Aflibercept Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Novartis Aflibercept Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Recent Developments
11.4 Genentech
11.4.1 Genentech Corporation Information
11.4.2 Genentech Overview
11.4.3 Genentech Aflibercept Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Genentech Aflibercept Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Genentech Recent Developments
11.5 Roche
11.5.1 Roche Corporation Information
11.5.2 Roche Overview
11.5.3 Roche Aflibercept Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Roche Aflibercept Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Roche Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Aflibercept Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Pfizer Aflibercept Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 Sartorius
11.7.1 Sartorius Corporation Information
11.7.2 Sartorius Overview
11.7.3 Sartorius Aflibercept Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Sartorius Aflibercept Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sartorius Recent Developments
11.8 Eli Lilly
11.8.1 Eli Lilly Corporation Information
11.8.2 Eli Lilly Overview
11.8.3 Eli Lilly Aflibercept Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Eli Lilly Aflibercept Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Eli Lilly Recent Developments
11.9 Bayer
11.9.1 Bayer Corporation Information
11.9.2 Bayer Overview
11.9.3 Bayer Aflibercept Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Bayer Aflibercept Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Bayer Recent Developments
11.10 Amgen
11.10.1 Amgen Corporation Information
11.10.2 Amgen Overview
11.10.3 Amgen Aflibercept Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Amgen Aflibercept Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Amgen Recent Developments
11.11 PlantForm
11.11.1 PlantForm Corporation Information
11.11.2 PlantForm Overview
11.11.3 PlantForm Aflibercept Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 PlantForm Aflibercept Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 PlantForm Recent Developments
11.12 PharmaPraxis
11.12.1 PharmaPraxis Corporation Information
11.12.2 PharmaPraxis Overview
11.12.3 PharmaPraxis Aflibercept Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 PharmaPraxis Aflibercept Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 PharmaPraxis Recent Developments
11.13 Samsung Bioepis
11.13.1 Samsung Bioepis Corporation Information
11.13.2 Samsung Bioepis Overview
11.13.3 Samsung Bioepis Aflibercept Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Samsung Bioepis Aflibercept Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Samsung Bioepis Recent Developments
11.14 Centus
11.14.1 Centus Corporation Information
11.14.2 Centus Overview
11.14.3 Centus Aflibercept Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Centus Aflibercept Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Centus Recent Developments
11.15 Cadila Pharmaceuticals
11.15.1 Cadila Pharmaceuticals Corporation Information
11.15.2 Cadila Pharmaceuticals Overview
11.15.3 Cadila Pharmaceuticals Aflibercept Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Cadila Pharmaceuticals Aflibercept Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Cadila Pharmaceuticals Recent Developments
11.16 Dr Reddy’s
11.16.1 Dr Reddy’s Corporation Information
11.16.2 Dr Reddy’s Overview
11.16.3 Dr Reddy’s Aflibercept Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Dr Reddy’s Aflibercept Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Dr Reddy’s Recent Developments
11.17 Aurobindo Pharma
11.17.1 Aurobindo Pharma Corporation Information
11.17.2 Aurobindo Pharma Overview
11.17.3 Aurobindo Pharma Aflibercept Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Aurobindo Pharma Aflibercept Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Aurobindo Pharma Recent Developments
11.18 Biocad
11.18.1 Biocad Corporation Information
11.18.2 Biocad Overview
11.18.3 Biocad Aflibercept Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Biocad Aflibercept Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Biocad Recent Developments
11.19 MAbxience
11.19.1 MAbxience Corporation Information
11.19.2 MAbxience Overview
11.19.3 MAbxience Aflibercept Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 MAbxience Aflibercept Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 MAbxience Recent Developments
11.20 Hetero
11.20.1 Hetero Corporation Information
11.20.2 Hetero Overview
11.20.3 Hetero Aflibercept Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Hetero Aflibercept Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Hetero Recent Developments
11.21 Biocon
11.21.1 Biocon Corporation Information
11.21.2 Biocon Overview
11.21.3 Biocon Aflibercept Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Biocon Aflibercept Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Biocon Recent Developments
11.22 Kirin Biologics
11.22.1 Kirin Biologics Corporation Information
11.22.2 Kirin Biologics Overview
11.22.3 Kirin Biologics Aflibercept Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Kirin Biologics Aflibercept Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Kirin Biologics Recent Developments
11.23 Mylan
11.23.1 Mylan Corporation Information
11.23.2 Mylan Overview
11.23.3 Mylan Aflibercept Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.23.4 Mylan Aflibercept Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Mylan Recent Developments
11.24 BeiGene
11.24.1 BeiGene Corporation Information
11.24.2 BeiGene Overview
11.24.3 BeiGene Aflibercept Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.24.4 BeiGene Aflibercept Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.24.5 BeiGene Recent Developments
11.25 Innovent
11.25.1 Innovent Corporation Information
11.25.2 Innovent Overview
11.25.3 Innovent Aflibercept Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.25.4 Innovent Aflibercept Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.25.5 Innovent Recent Developments
11.26 Qilu Pharmaceutical
11.26.1 Qilu Pharmaceutical Corporation Information
11.26.2 Qilu Pharmaceutical Overview
11.26.3 Qilu Pharmaceutical Aflibercept Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.26.4 Qilu Pharmaceutical Aflibercept Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.26.5 Qilu Pharmaceutical Recent Developments
11.27 Hengrui Pharmaceuticals
11.27.1 Hengrui Pharmaceuticals Corporation Information
11.27.2 Hengrui Pharmaceuticals Overview
11.27.3 Hengrui Pharmaceuticals Aflibercept Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.27.4 Hengrui Pharmaceuticals Aflibercept Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.27.5 Hengrui Pharmaceuticals Recent Developments
11.28 Hisun Pharmaceutical
11.28.1 Hisun Pharmaceutical Corporation Information
11.28.2 Hisun Pharmaceutical Overview
11.28.3 Hisun Pharmaceutical Aflibercept Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.28.4 Hisun Pharmaceutical Aflibercept Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.28.5 Hisun Pharmaceutical Recent Developments
11.29 TOT BIOPHARM
11.29.1 TOT BIOPHARM Corporation Information
11.29.2 TOT BIOPHARM Overview
11.29.3 TOT BIOPHARM Aflibercept Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.29.4 TOT BIOPHARM Aflibercept Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.29.5 TOT BIOPHARM Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Aflibercept Biosimilars Industry Chain Analysis
12.2 Aflibercept Biosimilars Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Aflibercept Biosimilars Production Mode & Process
12.4 Aflibercept Biosimilars Sales and Marketing
12.4.1 Aflibercept Biosimilars Sales Channels
12.4.2 Aflibercept Biosimilars Distributors
12.5 Aflibercept Biosimilars Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Aflibercept Biosimilars Industry Trends
13.2 Aflibercept Biosimilars Market Drivers
13.3 Aflibercept Biosimilars Market Challenges
13.4 Aflibercept Biosimilars Market Restraints
14 Key Findings in The Global Aflibercept Biosimilars Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer